ENST00000511747.6:c.47C>A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The ENST00000511747.6(SH3BP2):​c.47C>A​(p.Ala16Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000115 in 866,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A16V) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000012 ( 0 hom. )

Consequence

SH3BP2
ENST00000511747.6 missense

Scores

2
13

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.192

Publications

0 publications found
Variant links:
Genes affected
SH3BP2 (HGNC:10825): (SH3 domain binding protein 2) The protein encoded by this gene has an N-terminal pleckstrin homology (PH) domain, an SH3-binding proline-rich region, and a C-terminal SH2 domain. The protein binds to the SH3 domains of several proteins including the ABL1 and SYK protein tyrosine kinases , and functions as a cytoplasmic adaptor protein to positively regulate transcriptional activity in T, natural killer (NK), and basophilic cells. Mutations in this gene result in cherubism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
SH3BP2 Gene-Disease associations (from GenCC):
  • cherubism
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.13207555).

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000511747.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SH3BP2
NM_001122681.2
MANE Select
c.-4-2344C>A
intron
N/ANP_001116153.1A0A384N6E5
SH3BP2
NM_001145856.2
c.47C>Ap.Ala16Glu
missense
Exon 1 of 13NP_001139328.1P78314-4
SH3BP2
NM_001145855.2
c.81-2344C>A
intron
N/ANP_001139327.1P78314-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SH3BP2
ENST00000511747.6
TSL:1
c.47C>Ap.Ala16Glu
missense
Exon 1 of 13ENSP00000424846.2P78314-4
SH3BP2
ENST00000503393.8
TSL:1 MANE Select
c.-4-2344C>A
intron
N/AENSP00000422168.3P78314-1
SH3BP2
ENST00000932792.1
c.-125C>A
5_prime_UTR
Exon 1 of 12ENSP00000602851.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000115
AC:
1
AN:
866926
Hom.:
0
Cov.:
28
AF XY:
0.00
AC XY:
0
AN XY:
403240
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
16514
American (AMR)
AF:
0.00
AC:
0
AN:
2042
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
6060
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5470
South Asian (SAS)
AF:
0.00
AC:
0
AN:
17562
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
3864
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1794
European-Non Finnish (NFE)
AF:
0.00000128
AC:
1
AN:
784230
Other (OTH)
AF:
0.00
AC:
0
AN:
29390
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
7.0
DANN
Benign
0.93
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.024
N
LIST_S2
Benign
0.29
T
M_CAP
Pathogenic
0.66
D
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-0.90
T
PhyloP100
-0.19
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
-0.19
N
REVEL
Benign
0.15
Sift
Benign
0.20
T
Vest4
0.12
MutPred
0.17
Gain of solvent accessibility (P = 0.0488)
MVP
0.42
MPC
0.19
ClinPred
0.11
T
GERP RS
0.55
PromoterAI
-0.0041
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.3
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs868817457; hg19: chr4-2819997; API